{"id":"NCT02940886","sponsor":"Pharmacosmos A/S","briefTitle":"Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)","officialTitle":"A Phase III, Randomised, Open-label, Comparative Safety and Efficacy Trial of Intravenous Iron Isomaltoside/Ferric Derisomaltose (Monofer®/Monoferric®) and Iron Sucrose in Subjects With Iron Deficiency Anemia (FERWON-IDA)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-11-08","primaryCompletion":"2018-03-28","completion":"2018-03-28","firstPosted":"2016-10-21","resultsPosted":"2020-03-10","lastUpdate":"2020-10-06"},"enrollment":1512,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Iron Deficiency Anaemia","Iron Deficiency Anemia"],"interventions":[{"type":"DRUG","name":"Iron isomaltoside/ferric derisomaltose","otherNames":["Monofer®, Monoferric®, Monover®, Monofar®, Monoferro®"]},{"type":"DRUG","name":"Iron sucrose","otherNames":["Venofer®"]}],"arms":[{"label":"Iron isomaltoside/ferric derisomaltose","type":"EXPERIMENTAL"},{"label":"Iron sucrose","type":"ACTIVE_COMPARATOR"}],"summary":"Evaluate safety and efficacy of iron isomaltoside/ferric derisomaltose (Monofer®/Monoferric®) compared with iron sucrose (Venofer®), in subjects diagnosed with IDA.","primaryOutcome":{"measure":"Change in Hemoglobin (Hb) From Baseline to Week 8","timeFrame":"Baseline to week 8","effectByArm":[{"arm":"Iron Isomaltoside/Ferric Derisomaltose","deltaMin":2.49,"sd":null},{"arm":"Iron Sucrose","deltaMin":2.49,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":114,"countries":["United States"]},"refs":{"pmids":["31243803"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":21,"n":989},"commonTop":["Nausea"]}}